Onstryv - Safinamide - Brochure

Onstryv (safinamide) is a product licensed to Valeo Pharma by Zambon S.p.A and is the first new oral medication approved for Parkinson`s Disease in Canada in over 10 years. Parkinson`s Disease affects approximately 100,000 Canadians with approximately 6,600 new cases being diagnosed each year.